feedback

Faculty

Mark C. Petrie, MD

Scottish National Advanced Heart Failure Service
Golden Jubilee National Hospital
Glasgow, United Kingdom

Subodh Verma, MD, PhD

Division of Cardiac Surgery
St. Michael's Hospital
Department of Surgery
University of Toronto
Toronto, Canada

Kieran F. Docherty, MBChB

British Heart Foundation Cardiovascular Research Centre,
University of Glasgow, Glasgow, United Kingdom

Silvio E. Inzucchi, MD

Section of Endocrinology
Yale University School of Medicine
New Haven, CT

Inder Anand, MD, Dphil

Department of Cardiology,
University of Minnesota, Minneapolis

Jan Bělohlávek, MD, PhD

Second Department of Internal Medicine,
Cardiovascular Medicine, General Teaching Hospital,
First Faculty of Medicine, Charles University,
Prague, Czech Republic

Michael Böhm

Klinik für Innere Medizin III,
Kardiologie, Angiologie, und Internistische Intensivmedizin,
Universitätsklinikum des Saarlandes,
Homburg/Saar, Germany

Chern-En Chiang, MD, PhD

Division of Cardiology,
Taipei Veterans General Hospital, Taipei, Taiwan
National Yang-Ming University, Taipei, Taiwan

Vijay K. Chopra, MD

Department of Cardiology,
Medanta, Gurgaon, Haryana, India

Rudolf A. de Boer, MD, PhD

Department of Cardiology,
University Medical Center Groningen,
University of Groningen, Groningen, the Netherlands

Akshay S. Desai, MD, MPH

Cardiovascular Division
Brigham and Women's Hospital
Boston

Mirta Diez, MD

Division of Cardiology,
Instituto Cardiovascular de Buenos Aires,
Buenos Aires, Argentina

Jaroslaw Drozdz, MD, PhD

Medical University of Lodz
Lodz, Poland

Andre Dukát, MD, PhD

Fifth Department of Internal Medicine,
Comenius University in Bratislava,
Bratislava, Slovakia

Junbo Ge, MD

Shanghai Institute of Cardiovascular Disease,
Department of Cardiology,
Zhongshan Hospital Fudan University,
Shanghai, China

Jonathan Howlett, MD, PhD

Libin Cardiovascular Institute, Cumming School of Medicine,
University of Calgary, Calgary, Alberta, Canada

Tzvetana Katova, MD, PhD

Clinic of Cardiology, National Cardiology Hospital,
Sofia, Bulgaria

Masafumi Kitakaze, MD, PhD

Cardiovascular Division of Medicine,
National Cerebral and Cardiovascular Center,
Osaka, Japan

Charlotta E. A. Ljungman, MD, PhD

Institute of Medicine,
Department of Molecular and Clinical Medicine/Cardiology,
Sahlgrenska Academy, University of Gothenburg,
Gothenburg, Sweden

Béla Merkely, MD

Semmelweis Medical University
Budapest, Hungary

Jose C. Nicolau, MD, PhD

Instituto do Coração–Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
São Paulo

Eileen O'Meara, MD

Montreal Heart Institute
Montreal

Pham Nguyen Vinh, MD, PhD

Department of Internal Medicine,
Tan Tao University, Tan Duc, Vietnam

Morten Schou, MD, PhD

Department of Cardiology,
Gentofte University Hospital Copenhagen,
Copenhagen, Denmark

Sergey Tereshchenko, MD, PhD

Department of Myocardial Disease and Heart Failure,
National Medical Research Center of Cardiology,
Moscow, Russia

Lars Køber, MD, DSc

Department of Cardiology
Rigshospitalet
Copenhagen University Hospital
Emergency Medical Services Copenhagen
Copenhagen, Denmark

Mikhail N. Kosiborod, MD

St Luke's Mid America Heart Institute,
University of Missouri-Kansas City, Kansas City

Anna Maria Langkilde, MD, PhD

Late Stage Development, Cardiovascular, Renal and Metabolism,
BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Felipe A. Martinez, MD

Universidad Nacional de Córdoba, Córdoba, Argentina

Piotr Ponikowski, MD, PhD

Center for Heart Diseases, University Hospital,
Wroclaw Medical University, Wroclaw, Poland

Marc S. Sabatine, MD, MPH

Cardiovascular Division,
Brigham and Women's Hospital,
Boston, Massachusetts

Mikaela Sjöstrand, MD, PhD

Late Stage Development, Cardiovascular, Renal and Metabolism,
BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Scott D. Solomon, MD

Cardiovascular Division
Brigham and Women's Hospital
Boston

Per Johanson, MD, PhD

Late Stage Development, Cardiovascular, Renal and Metabolism,
BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Peter J. Greasley, PhD

Early Discovery and Development, Cardiovascular, Renal and Metabolism,
BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

David Boulton, PhD

Clinical Pharmacology and Safety Sciences,
BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland

Olof Bengtsson, PhLic

Late Stage Development, Cardiovascular, Renal and Metabolism,
BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Pardeep S. Jhund, MBChB, MSc, PhD

British Heart Foundation Cardiovascular Research Centre,
University of Glasgow, Glasgow, United Kingdom

John J. V. McMurray, MD

British Heart Foundation Cardiovascular Research Centre,
University of Glasgow, Glasgow, United Kingdom

Accredited by

American Medical Association

View Activity Materials

Course Description

To learn about clinical outcomes associated with dapagliflozin treatment in patients who have heart failure with reduced ejection fraction.

Activity Details

Credit Types:CME / MOC
Credit Amount:1.00 Credits
Release Date:2020-Apr-14
Expiration Date:2023-Apr-14
Estimated Time for Completion:1 hour
Registration Required:Yes
Cost:$30.00

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.